The effect of oral vitamin D and vitamin B on Treatment of vitiligo
Phase 2
- Conditions
- Vitiligo.Vitiligo
- Registration Number
- IRCT2016100527404N4
- Lead Sponsor
- VITABIOTICS Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
1-patients with stable vitiligo
2-Aged between 12 and 60 years.
3-not pregnant or lactating.
4-not acral vitiligo
5-There is not history of severe nephrolithiasis and hypersensitivity to vitamin D or vitamin B.
6-Involvement less than 20% body surface area.
7-Site of the lesion not on the face.
8-No Prohibition use of methoxsalen.
Exclusion criteria:
1-lack of desire to continue cooperation
2-pregnant patients during the study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pigmentation. Timepoint: Before and after treatment. Method of measurement: VASI score.;Extent lesion. Timepoint: Before and after treatment. Method of measurement: VASI score.;Peri follicular repigmentation. Timepoint: Before and after treatment. Method of measurement: questionnaire.
- Secondary Outcome Measures
Name Time Method Erythema. Timepoint: In 1,2,3,4,5,6 month treatment. Method of measurement: questionnaire.;Blisters. Timepoint: In 1,2,3,4,5,6 month treatment. Method of measurement: questionnaire.;Itching. Timepoint: In 1,2,3,4,5,6 month treatment. Method of measurement: questionnaire.;The recurrence. Timepoint: In 1,2,3,4,5,6 month treatment. Method of measurement: questionnaire.